Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ritter

Showing results (411-420 of 540) with videos related to

Pageof 54
Sort By:
Cancer Research|June 5, 2001
Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenograftsF T Lee, A Rigopoulos, C Hall, et al.
Human Molecular Genetics|January 1, 1996
Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseasesD Phaneuf, N Wakamatsu, J Q Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 1997
The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamilyJ K Heath, S J White, C N Johnstone, et al.
The Journal of Biological Chemistry|October 11, 1996
Purification and characterization of a novel restricted antigen expressed by normal and transformed human colonic epitheliumB Catimel, G Ritter, S Welt, et al.
Nature Communications|April 16, 2024
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infectionChang Liu, Raksha Das, Aiste Dijokaite-Guraliuc, et al.
Cancer Research|June 24, 2000
Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumorsA M Scott, D Geleick, M Rubira, et al.
Preparative Biochemistry & Biotechnology|May 11, 2005
Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditionsR Murphy, S Green, G Ritter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2001
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trialA M Scott, F T Lee, W Hopkins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2021
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare WorkersSheila F Lumley, Jia Wei, Denise O'Donnell, et al.
Cell Reports. Medicine|May 9, 2024
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinityChang Liu, Daming Zhou, Aiste Dijokaite-Guraliuc, et al.
Pageof 54

Showing results (411-420 of 540) with videos related to

Sort By:
Pageof 54
Cancer Research|June 5, 2001
Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenograftsF T Lee, A Rigopoulos, C Hall, et al.
Human Molecular Genetics|January 1, 1996
Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseasesD Phaneuf, N Wakamatsu, J Q Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 1997
The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamilyJ K Heath, S J White, C N Johnstone, et al.
The Journal of Biological Chemistry|October 11, 1996
Purification and characterization of a novel restricted antigen expressed by normal and transformed human colonic epitheliumB Catimel, G Ritter, S Welt, et al.
Nature Communications|April 16, 2024
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infectionChang Liu, Raksha Das, Aiste Dijokaite-Guraliuc, et al.
Cancer Research|June 24, 2000
Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumorsA M Scott, D Geleick, M Rubira, et al.
Preparative Biochemistry & Biotechnology|May 11, 2005
Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditionsR Murphy, S Green, G Ritter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2001
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trialA M Scott, F T Lee, W Hopkins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2021
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare WorkersSheila F Lumley, Jia Wei, Denise O'Donnell, et al.
Cell Reports. Medicine|May 9, 2024
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinityChang Liu, Daming Zhou, Aiste Dijokaite-Guraliuc, et al.
Pageof 54